Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 With DAC 5mg | Research Peptide

Description CJC1295 With DAC is a premium grade (99%+ purity) research peptide in lyophilized solid (freeze dried) form. Sealed with a self healing rubber stopper in a 3ml vial under negative pressure. Protected by a plastic and metal cap. Product Name: CJC1295 With DAC Peptide Colour: White Type: GHRH Anaog with DAC Length: 30 Amino Acids Molecular Weight: 3,647.28 DA Half Life: 1 week Each peptide is third party sample tested with a Certificate of Analysis (COA) for mass and purity. Lyophilized Solid Form: -20°C away from UV Light Reconstituted Form: 2°C - 6°C away from UV Light To be reconstituted (see instructional video). This product is in its lyophilized powder form (freeze dried). These products are provided strictly for research purposes only. They are not intended for human or animal consumption, clinical use, diagnostic use or therapeutic application.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Description

CJC1295 With DAC is a premium grade (99%+ purity) research peptide in lyophilized solid (freeze dried) form. Sealed with a self healing rubber stopper in a 3ml vial under negative pressure. Protected by a plastic and metal cap.

Product Name: CJC1295 With DAC Peptide Colour: White Type: GHRH Anaog with DAC Length: 30 Amino Acids Molecular Weight: 3,647.28 DA Half Life: 1 week

Each peptide is third party sample tested with a Certificate of Analysis (COA) for mass and purity.

Lyophilized Solid Form: -20°C away from UV Light

Reconstituted Form: 2°C - 6°C away from UV Light

To be reconstituted (see instructional video).

This product is in its lyophilized powder form (freeze dried).

These products are provided strictly for research purposes only. They are not intended for human or animal consumption, clinical use, diagnostic use or therapeutic application.

Connected topics

Follow this recovery question